Treatment considerations for MGMT-unmethylated glioblastoma.

Treatment considerations for MGMT-unmethylated glioblastoma.

Item
http://www.wikidata.org/entity/Q38267992
Current trends in the surgical management and treatment of adult glioblastomaMALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer.Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3.Towards Targeting PI3K-Dependent Regulation of Gene Expression in Brain CancerKnockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells.Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients.
P2860

Treatment considerations for MGMT-unmethylated glioblastoma.

Item
http://www.wikidata.org/entity/Q38267992
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Treatment considerations for MGMT-unmethylated glioblastoma.
@en
type
label
Treatment considerations for MGMT-unmethylated glioblastoma.
@en
prefLabel
Treatment considerations for MGMT-unmethylated glioblastoma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Treatment considerations for MGMT-unmethylated glioblastoma.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698